RXi Pharmaceuticals has appointed Richard Chin to its board of directors.
Chin is currently CEO of non-profit pharmaceutical company OneWorld Health. He previously served in various positions at OxiGene, Elan, and Genentech. He holds a BA in biology from Harvard University and a law degree from Oxford University.
Dicerna Pharmaceuticals announced that the Proceedings of the National Academy of Sciences' editorial board has awarded company co-founder and City of Hope researcher John Rossi has been awarded the 2008 Cozzarelli Prize.
Rossi received the award for his work on a publication entitled, "MicroRNA-Directed Transcriptional Gene Silencing in Mammalian Cells," the company said.
Opko Health has appointed Alice Lin-Tsing to its board of directors, according to a company filing with the US Securities and Exchange Commission.
Lin-Tsing is a researcher at the Genomics Research Center, Academia Sinica, in Taiwan. She is also a professor at the National Taiwan University and University of California, San Diego.
Benitec announced that Kenneth Reed, a non-executive director and company co-founder, has resigned from the firm's board. He remains the chair of Benitec's scientific advisory board.
According to the company, Reed stepped down in order to continue on as a researcher at the City of Hope.